These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3026689)

  • 1. Competitive inhibitor binding assay (CIBA) of captopril and other ACE inhibitors.
    Grönhagen-Riska C; Tikkanen I; Fyhrquist F
    Clin Chim Acta; 1987 Jan; 162(1):53-60. PubMed ID: 3026689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive inhibitor binding assay (CIBA) of ACE inhibitors.
    Grönhagen-Riska C; Tikkanen I; Fyhrquist F
    Acta Med Scand Suppl; 1986; 714():43-7. PubMed ID: 3033999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive inhibitor binding assay (IBA) of captopril and other inhibitors of angiotensin converting enzyme.
    Tikkanen FF; Grönhagen-Riska C
    Scand J Urol Nephrol Suppl; 1984; 79():13-6. PubMed ID: 6089313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive Inhibitor Binding Assay (IBA) of Captopril and Other Inhibitors of Angiotensin Converting Enzyme.
    Tikkanen FF; Grönhagen-Riska C
    Scand J Urol Nephrol; 1984 Jul; 18(sup79):13-16. PubMed ID: 27786018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor binding assay for angiotensin-converting enzyme.
    Fyhrquist F; Tikkanen I; Grönhagen-Riska C; Hortling L; Hichens M
    Clin Chem; 1984 May; 30(5):696-700. PubMed ID: 6325041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor binding assay of rat serum angiotensin converting enzyme.
    Tikkanen I; Fyhrquist F; Forslund T
    Clin Sci (Lond); 1984 Aug; 67(2):237-41. PubMed ID: 6086211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
    Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI
    Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation.
    Daud AI; Bumpus FM; Husain A
    Endocrinology; 1990 Jun; 126(6):2927-35. PubMed ID: 2161740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
    Bünning P
    Arzneimittelforschung; 1984; 34(10B):1406-10. PubMed ID: 6097266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay.
    Jackson B; Cubela R; Johnston CI
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):699-704. PubMed ID: 2442537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.
    Bull HG; Thornberry NA; Cordes MH; Patchett AA; Cordes EH
    J Biol Chem; 1985 Mar; 260(5):2952-62. PubMed ID: 2982845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ.
    Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN
    J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of angiotensin converting enzyme inhibitors in serum by radioinhibitor binding displacement assay.
    Jackson B; Cubela R; Johnston CI
    Biochem Pharmacol; 1987 Apr; 36(8):1357-60. PubMed ID: 3036166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
    Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
    Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography--mass spectrometry and its application to pharmacokinetic studies.
    Franklin ME; Addison RS; Baker PV; Hooper WD
    J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):47-54. PubMed ID: 9498669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
    Thwaites DT; Cavet M; Hirst BH; Simmons NL
    Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.